Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Information Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,773 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,607 · Balance 41,401 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,084 · Balance 42,485 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 1,995 · Balance 44,480 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,360 · Balance 45,840 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,067 · Balance 42,773 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,607 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,084 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,978 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 1,995 · Balance 7,978 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,162 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,360 · Balance 8,162 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2025 Filed Apr 2, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000118 · wk-form4_1743629812.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000118 · wk-form4_1743629812.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:27 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 3,500 | $43.16 | $151,060.35 |
DisclosureSEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,720 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 637 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,187 Underlying: Common Stock · 637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 228 | $42.89 | $9,778.92 |
DisclosureSEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,220 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:41 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 16,242 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000076 · wk-form4_1741898504.xml · derivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,242 Underlying: Common Stock · 16,242 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:41 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 24,363 | $0.00 Strike: $43.10 | $0.00 |
DisclosureSEC source: 0001576280-25-000076 · wk-form4_1741898504.xml · derivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,363 Underlying: Common Stock · 24,363 shares Expires 2035-03-12 F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000058 · wk-form4_1741130014.xml · derivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421 Underlying: Common Stock · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022, the remaining 75% of the shares subject to such award vest in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 3,696 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000058 · wk-form4_1741130014.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,394 Underlying: Common Stock · 3,696 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,590 | $42.55 | $67,654.50 |
DisclosureSEC source: 0001576280-25-000058 · wk-form4_1741130014.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,811 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000058 · wk-form4_1741130014.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000058 · wk-form4_1741130014.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,083 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000016 · wk-form4_1735945245.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,587 Underlying: Common Stock · 1,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000016 · wk-form4_1735945245.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,249 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,103 | $30.55 | $33,696.65 |
DisclosureSEC source: 0001576280-25-000016 · wk-form4_1735945245.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,995 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000016 · wk-form4_1735945245.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000016 · wk-form4_1735945245.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 637 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000309 · wk-form4_1734391530.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,824 Underlying: Common Stock · 637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 323 | $34.76 | $11,227.48 |
DisclosureSEC source: 0001576280-24-000309 · wk-form4_1734391530.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,408 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000309 · wk-form4_1734391530.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000293 · wk-form4_1733185527.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,131 Underlying: Common Stock · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award vest in equal installments on each quarterly anniversary of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 360 | $35.61 | $12,819.60 |
DisclosureSEC source: 0001576280-24-000293 · wk-form4_1733185527.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,094 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000293 · wk-form4_1733185527.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 22:13 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 7,000 | $29.25 | $204,722.00 |
DisclosureSEC source: 0001576280-24-000287 · wk-form4_1732054393.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,744 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $29.23 to $29.31. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 23,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000273 · wk-form4_1731453206.xml · derivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,814 Underlying: Common Stock · 23,814 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:13 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 35,721 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001576280-24-000273 · wk-form4_1731453206.xml · derivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,721 Underlying: Common Stock · 35,721 shares Expires 2034-11-08 F1 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,270 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000240 · wk-form4_1727902475.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,670 Underlying: Common Stock · 4,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000240 · wk-form4_1727902475.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,856 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,980 | $22.12 | $65,917.60 |
DisclosureSEC source: 0001576280-24-000240 · wk-form4_1727902475.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,744 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000240 · wk-form4_1727902475.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000240 · wk-form4_1727902475.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000218 · wk-form4_1726522257.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,461 Underlying: Common Stock · 638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 324 | $26.79 | $8,679.96 |
DisclosureSEC source: 0001576280-24-000218 · wk-form4_1726522257.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,847 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000218 · wk-form4_1726522257.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 21:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,545 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000208 · wk-form4_1726002009.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award annually commencing on September 9, 2020. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 21:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,318 | $23.77 | $78,868.86 |
DisclosureSEC source: 0001576280-24-000208 · wk-form4_1726002009.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,533 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 21:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000208 · wk-form4_1726002009.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000200 · wk-form4_1725396392.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,841 Underlying: Common Stock · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 360 | $25.58 | $9,208.80 |
DisclosureSEC source: 0001576280-24-000200 · wk-form4_1725396392.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,306 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000200 · wk-form4_1725396392.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000170 · wk-form4_1719953826.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,463 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 574 | $28.26 | $16,221.24 |
DisclosureSEC source: 0001576280-24-000170 · wk-form4_1719953826.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,956 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000170 · wk-form4_1719953826.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:41 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 2,510 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000150 · wk-form4_1718664073.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,099 Underlying: Common Stock · 2,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:41 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 896 | $30.21 | $27,068.16 |
DisclosureSEC source: 0001576280-24-000150 · wk-form4_1718664073.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,923 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:41 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 2,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000150 · wk-form4_1718664073.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:23 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 711 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000126 · wk-form4_1717453405.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,551 Underlying: Common Stock · 711 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:23 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 254 | $27.10 | $6,883.40 |
DisclosureSEC source: 0001576280-24-000126 · wk-form4_1717453405.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,309 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:23 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000126 · wk-form4_1717453405.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.